Utility of non-HDL-C and apoB targets in the context of new more aggressive lipid guidelines

OBJECTIVE: Major guidelines recommend the use of secondary targets, such as non-HDL-C and apoB, to further reduce cardiovascular risk. We aimed to evaluate the proportion at which newer, more aggressive secondary lipid targets are exceeded in patients with LDL-C < 70 mg/dL estimated by Friedewald...

Descripción completa

Detalles Bibliográficos
Autores principales: Quispe, Renato, Brownstein, Adam J., Sathiyakumar, Vasanth, Park, Jihwan, Chang, Blair, Sajja, Aparna, Guallar, Eliseo, Lazo, Mariana, Jones, Steven R., Martin, Seth S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387302/
https://www.ncbi.nlm.nih.gov/pubmed/34611642
http://dx.doi.org/10.1016/j.ajpc.2021.100203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387302/
https://www.ncbi.nlm.nih.gov/pubmed/34611642
http://dx.doi.org/10.1016/j.ajpc.2021.100203

Ejemplares similares